Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort

Aims The aim of this study was to examine whether high-sensitivity C-reactive protein (hs-CRP), N-terminal pro-brain natriuretic peptide (NT-proBNP), and soluble urokinase plasminogen activator receptor (suPAR) carried incremental prognostic value in predicting cardiovascular morbidity and mortality...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of preventive cardiology 2020-04, Vol.27 (6), p.570-578
Hauptverfasser: Frary, Charles Edward, Blicher, Marie Kofoed, Olesen, Thomas Bastholm, Stidsen, Jacob Volmer, Greve, Sara Vikström, Vishram-Nielsen, Julie KK, Rasmussen, Susanne Lone, Olsen, Michael Hecht, Pareek, Manan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 578
container_issue 6
container_start_page 570
container_title European journal of preventive cardiology
container_volume 27
creator Frary, Charles Edward
Blicher, Marie Kofoed
Olesen, Thomas Bastholm
Stidsen, Jacob Volmer
Greve, Sara Vikström
Vishram-Nielsen, Julie KK
Rasmussen, Susanne Lone
Olsen, Michael Hecht
Pareek, Manan
description Aims The aim of this study was to examine whether high-sensitivity C-reactive protein (hs-CRP), N-terminal pro-brain natriuretic peptide (NT-proBNP), and soluble urokinase plasminogen activator receptor (suPAR) carried incremental prognostic value in predicting cardiovascular morbidity and mortality beyond traditional risk factors in apparently healthy individuals. Methods and results This was a prospective population-based cohort study comprising 1951 subjects included in the 10-year follow-up of the MONItoring of trends and determinants in CArdiovascular disease (MONICA) study, between 1993 and 1994. The principal endpoint was death from cardiovascular causes. Secondary endpoints were death from any cause, coronary artery disease, heart failure, and cerebrovascular disease. Predictive capabilities of each of the three biomarkers were tested using Cox proportional-hazards regression, Harrell’s concordance index (C-index), and net reclassification improvement (NRI). Study participants were aged 41, 51, 61, or 71 years, and equally distributed between the two sexes. During a median follow-up of 18.5 years (interquartile range: 18.1–19.0), 177 (9.1%) subjects died from a cardiovascular cause. Hs-CRP (adjusted standardized hazard ratio (HR): 1.37, 95% confidence interval (CI): 1.17–1.60), NT-proBNP (HR: 1.90, 95% CI: 1.58–2.29), and suPAR (HR: 1.35, 95% CI: 1.17–1.57) were all significantly associated with cardiovascular deaths after adjustment for age, sex, smoking status, systolic blood pressure, and total cholesterol (p 
doi_str_mv 10.1177/2047487319885457
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2314248168</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_2047487319885457</sage_id><sourcerecordid>2314248168</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-be3b2e7e80735065214683b03323fe31450a375d162eaef3550bda92dfcc43ab3</originalsourceid><addsrcrecordid>eNp1kDtPwzAURi0EAlTYmZBHloAfcW1GVPGSCiwwR45z0xqSuFw7SJ3547gqMCDhwbauznek-xFywtk551pfCFbq0mjJL41RpdI75HAzKkpj-O7vX8sDchzjK8tnyoQwZp8cSK65EUofks-ZRzd2NvlhQWsfeotvgJG2AWkXhkWRAHvqLDY-fNi4QZGij280Jsyp1rt8h4H6gdrVyiIMqVvTJdguLdd52vgP34y2y0oMPU1LoA9Pj_ezK8oZdWEZMB2RvTYDcPz9TsjLzfXz7K6YP91mcF44KXUqapC1AA2GaanYVAleTo2smZRCtiB5qZiVWjV8KsBCK5VidWMvRdM6V0pbywk523pXGN5HiKnqfXTQdXaAMMZKZIcoDc_WCWFb1GGIEaGtVuhzN-uKs2rTfvW3_Rw5_baPdQ_Nb-Cn6wwUWyDaBVSvYcQhb_u_8Av1HY3G</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2314248168</pqid></control><display><type>article</type><title>Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort</title><source>MEDLINE</source><source>SAGE Complete A-Z List</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Frary, Charles Edward ; Blicher, Marie Kofoed ; Olesen, Thomas Bastholm ; Stidsen, Jacob Volmer ; Greve, Sara Vikström ; Vishram-Nielsen, Julie KK ; Rasmussen, Susanne Lone ; Olsen, Michael Hecht ; Pareek, Manan</creator><creatorcontrib>Frary, Charles Edward ; Blicher, Marie Kofoed ; Olesen, Thomas Bastholm ; Stidsen, Jacob Volmer ; Greve, Sara Vikström ; Vishram-Nielsen, Julie KK ; Rasmussen, Susanne Lone ; Olsen, Michael Hecht ; Pareek, Manan</creatorcontrib><description>Aims The aim of this study was to examine whether high-sensitivity C-reactive protein (hs-CRP), N-terminal pro-brain natriuretic peptide (NT-proBNP), and soluble urokinase plasminogen activator receptor (suPAR) carried incremental prognostic value in predicting cardiovascular morbidity and mortality beyond traditional risk factors in apparently healthy individuals. Methods and results This was a prospective population-based cohort study comprising 1951 subjects included in the 10-year follow-up of the MONItoring of trends and determinants in CArdiovascular disease (MONICA) study, between 1993 and 1994. The principal endpoint was death from cardiovascular causes. Secondary endpoints were death from any cause, coronary artery disease, heart failure, and cerebrovascular disease. Predictive capabilities of each of the three biomarkers were tested using Cox proportional-hazards regression, Harrell’s concordance index (C-index), and net reclassification improvement (NRI). Study participants were aged 41, 51, 61, or 71 years, and equally distributed between the two sexes. During a median follow-up of 18.5 years (interquartile range: 18.1–19.0), 177 (9.1%) subjects died from a cardiovascular cause. Hs-CRP (adjusted standardized hazard ratio (HR): 1.37, 95% confidence interval (CI): 1.17–1.60), NT-proBNP (HR: 1.90, 95% CI: 1.58–2.29), and suPAR (HR: 1.35, 95% CI: 1.17–1.57) were all significantly associated with cardiovascular deaths after adjustment for age, sex, smoking status, systolic blood pressure, and total cholesterol (p &lt; 0.001 for all). Furthermore, all three biomarkers were significantly associated with significant NRI. However, only NT-proBNP significantly raised the C-index in predicting death from cardiovascular causes when added to the risk factors (C-index 0.860 versus 0.847; p = 0.02). Conclusions Hs-CRP, suPAR, and particularly NT-proBNP predicted cardiovascular death and may enhance prognostication beyond traditional risk factors in apparently healthy individuals.</description><identifier>ISSN: 2047-4873</identifier><identifier>EISSN: 2047-4881</identifier><identifier>DOI: 10.1177/2047487319885457</identifier><identifier>PMID: 31718257</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Adult ; Aged ; Biomarkers - blood ; C-Reactive Protein - analysis ; Cardiovascular Diseases - blood ; Cardiovascular Diseases - diagnosis ; Cardiovascular Diseases - mortality ; Denmark - epidemiology ; Female ; Heart Disease Risk Factors ; Humans ; Male ; Middle Aged ; Natriuretic Peptide, Brain - blood ; Peptide Fragments - blood ; Predictive Value of Tests ; Prognosis ; Receptors, Urokinase Plasminogen Activator - blood ; Risk Assessment ; Time Factors</subject><ispartof>European journal of preventive cardiology, 2020-04, Vol.27 (6), p.570-578</ispartof><rights>The European Society of Cardiology 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-be3b2e7e80735065214683b03323fe31450a375d162eaef3550bda92dfcc43ab3</citedby><cites>FETCH-LOGICAL-c337t-be3b2e7e80735065214683b03323fe31450a375d162eaef3550bda92dfcc43ab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/2047487319885457$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/2047487319885457$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21819,27924,27925,43621,43622</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31718257$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Frary, Charles Edward</creatorcontrib><creatorcontrib>Blicher, Marie Kofoed</creatorcontrib><creatorcontrib>Olesen, Thomas Bastholm</creatorcontrib><creatorcontrib>Stidsen, Jacob Volmer</creatorcontrib><creatorcontrib>Greve, Sara Vikström</creatorcontrib><creatorcontrib>Vishram-Nielsen, Julie KK</creatorcontrib><creatorcontrib>Rasmussen, Susanne Lone</creatorcontrib><creatorcontrib>Olsen, Michael Hecht</creatorcontrib><creatorcontrib>Pareek, Manan</creatorcontrib><title>Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort</title><title>European journal of preventive cardiology</title><addtitle>Eur J Cardiovasc Prev Rehabil</addtitle><description>Aims The aim of this study was to examine whether high-sensitivity C-reactive protein (hs-CRP), N-terminal pro-brain natriuretic peptide (NT-proBNP), and soluble urokinase plasminogen activator receptor (suPAR) carried incremental prognostic value in predicting cardiovascular morbidity and mortality beyond traditional risk factors in apparently healthy individuals. Methods and results This was a prospective population-based cohort study comprising 1951 subjects included in the 10-year follow-up of the MONItoring of trends and determinants in CArdiovascular disease (MONICA) study, between 1993 and 1994. The principal endpoint was death from cardiovascular causes. Secondary endpoints were death from any cause, coronary artery disease, heart failure, and cerebrovascular disease. Predictive capabilities of each of the three biomarkers were tested using Cox proportional-hazards regression, Harrell’s concordance index (C-index), and net reclassification improvement (NRI). Study participants were aged 41, 51, 61, or 71 years, and equally distributed between the two sexes. During a median follow-up of 18.5 years (interquartile range: 18.1–19.0), 177 (9.1%) subjects died from a cardiovascular cause. Hs-CRP (adjusted standardized hazard ratio (HR): 1.37, 95% confidence interval (CI): 1.17–1.60), NT-proBNP (HR: 1.90, 95% CI: 1.58–2.29), and suPAR (HR: 1.35, 95% CI: 1.17–1.57) were all significantly associated with cardiovascular deaths after adjustment for age, sex, smoking status, systolic blood pressure, and total cholesterol (p &lt; 0.001 for all). Furthermore, all three biomarkers were significantly associated with significant NRI. However, only NT-proBNP significantly raised the C-index in predicting death from cardiovascular causes when added to the risk factors (C-index 0.860 versus 0.847; p = 0.02). Conclusions Hs-CRP, suPAR, and particularly NT-proBNP predicted cardiovascular death and may enhance prognostication beyond traditional risk factors in apparently healthy individuals.</description><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers - blood</subject><subject>C-Reactive Protein - analysis</subject><subject>Cardiovascular Diseases - blood</subject><subject>Cardiovascular Diseases - diagnosis</subject><subject>Cardiovascular Diseases - mortality</subject><subject>Denmark - epidemiology</subject><subject>Female</subject><subject>Heart Disease Risk Factors</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Natriuretic Peptide, Brain - blood</subject><subject>Peptide Fragments - blood</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Receptors, Urokinase Plasminogen Activator - blood</subject><subject>Risk Assessment</subject><subject>Time Factors</subject><issn>2047-4873</issn><issn>2047-4881</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kDtPwzAURi0EAlTYmZBHloAfcW1GVPGSCiwwR45z0xqSuFw7SJ3547gqMCDhwbauznek-xFywtk551pfCFbq0mjJL41RpdI75HAzKkpj-O7vX8sDchzjK8tnyoQwZp8cSK65EUofks-ZRzd2NvlhQWsfeotvgJG2AWkXhkWRAHvqLDY-fNi4QZGij280Jsyp1rt8h4H6gdrVyiIMqVvTJdguLdd52vgP34y2y0oMPU1LoA9Pj_ezK8oZdWEZMB2RvTYDcPz9TsjLzfXz7K6YP91mcF44KXUqapC1AA2GaanYVAleTo2smZRCtiB5qZiVWjV8KsBCK5VidWMvRdM6V0pbywk523pXGN5HiKnqfXTQdXaAMMZKZIcoDc_WCWFb1GGIEaGtVuhzN-uKs2rTfvW3_Rw5_baPdQ_Nb-Cn6wwUWyDaBVSvYcQhb_u_8Av1HY3G</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Frary, Charles Edward</creator><creator>Blicher, Marie Kofoed</creator><creator>Olesen, Thomas Bastholm</creator><creator>Stidsen, Jacob Volmer</creator><creator>Greve, Sara Vikström</creator><creator>Vishram-Nielsen, Julie KK</creator><creator>Rasmussen, Susanne Lone</creator><creator>Olsen, Michael Hecht</creator><creator>Pareek, Manan</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202004</creationdate><title>Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort</title><author>Frary, Charles Edward ; Blicher, Marie Kofoed ; Olesen, Thomas Bastholm ; Stidsen, Jacob Volmer ; Greve, Sara Vikström ; Vishram-Nielsen, Julie KK ; Rasmussen, Susanne Lone ; Olsen, Michael Hecht ; Pareek, Manan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-be3b2e7e80735065214683b03323fe31450a375d162eaef3550bda92dfcc43ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers - blood</topic><topic>C-Reactive Protein - analysis</topic><topic>Cardiovascular Diseases - blood</topic><topic>Cardiovascular Diseases - diagnosis</topic><topic>Cardiovascular Diseases - mortality</topic><topic>Denmark - epidemiology</topic><topic>Female</topic><topic>Heart Disease Risk Factors</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Natriuretic Peptide, Brain - blood</topic><topic>Peptide Fragments - blood</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Receptors, Urokinase Plasminogen Activator - blood</topic><topic>Risk Assessment</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Frary, Charles Edward</creatorcontrib><creatorcontrib>Blicher, Marie Kofoed</creatorcontrib><creatorcontrib>Olesen, Thomas Bastholm</creatorcontrib><creatorcontrib>Stidsen, Jacob Volmer</creatorcontrib><creatorcontrib>Greve, Sara Vikström</creatorcontrib><creatorcontrib>Vishram-Nielsen, Julie KK</creatorcontrib><creatorcontrib>Rasmussen, Susanne Lone</creatorcontrib><creatorcontrib>Olsen, Michael Hecht</creatorcontrib><creatorcontrib>Pareek, Manan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of preventive cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Frary, Charles Edward</au><au>Blicher, Marie Kofoed</au><au>Olesen, Thomas Bastholm</au><au>Stidsen, Jacob Volmer</au><au>Greve, Sara Vikström</au><au>Vishram-Nielsen, Julie KK</au><au>Rasmussen, Susanne Lone</au><au>Olsen, Michael Hecht</au><au>Pareek, Manan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort</atitle><jtitle>European journal of preventive cardiology</jtitle><addtitle>Eur J Cardiovasc Prev Rehabil</addtitle><date>2020-04</date><risdate>2020</risdate><volume>27</volume><issue>6</issue><spage>570</spage><epage>578</epage><pages>570-578</pages><issn>2047-4873</issn><eissn>2047-4881</eissn><abstract>Aims The aim of this study was to examine whether high-sensitivity C-reactive protein (hs-CRP), N-terminal pro-brain natriuretic peptide (NT-proBNP), and soluble urokinase plasminogen activator receptor (suPAR) carried incremental prognostic value in predicting cardiovascular morbidity and mortality beyond traditional risk factors in apparently healthy individuals. Methods and results This was a prospective population-based cohort study comprising 1951 subjects included in the 10-year follow-up of the MONItoring of trends and determinants in CArdiovascular disease (MONICA) study, between 1993 and 1994. The principal endpoint was death from cardiovascular causes. Secondary endpoints were death from any cause, coronary artery disease, heart failure, and cerebrovascular disease. Predictive capabilities of each of the three biomarkers were tested using Cox proportional-hazards regression, Harrell’s concordance index (C-index), and net reclassification improvement (NRI). Study participants were aged 41, 51, 61, or 71 years, and equally distributed between the two sexes. During a median follow-up of 18.5 years (interquartile range: 18.1–19.0), 177 (9.1%) subjects died from a cardiovascular cause. Hs-CRP (adjusted standardized hazard ratio (HR): 1.37, 95% confidence interval (CI): 1.17–1.60), NT-proBNP (HR: 1.90, 95% CI: 1.58–2.29), and suPAR (HR: 1.35, 95% CI: 1.17–1.57) were all significantly associated with cardiovascular deaths after adjustment for age, sex, smoking status, systolic blood pressure, and total cholesterol (p &lt; 0.001 for all). Furthermore, all three biomarkers were significantly associated with significant NRI. However, only NT-proBNP significantly raised the C-index in predicting death from cardiovascular causes when added to the risk factors (C-index 0.860 versus 0.847; p = 0.02). Conclusions Hs-CRP, suPAR, and particularly NT-proBNP predicted cardiovascular death and may enhance prognostication beyond traditional risk factors in apparently healthy individuals.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>31718257</pmid><doi>10.1177/2047487319885457</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2047-4873
ispartof European journal of preventive cardiology, 2020-04, Vol.27 (6), p.570-578
issn 2047-4873
2047-4881
language eng
recordid cdi_proquest_miscellaneous_2314248168
source MEDLINE; SAGE Complete A-Z List; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Adult
Aged
Biomarkers - blood
C-Reactive Protein - analysis
Cardiovascular Diseases - blood
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - mortality
Denmark - epidemiology
Female
Heart Disease Risk Factors
Humans
Male
Middle Aged
Natriuretic Peptide, Brain - blood
Peptide Fragments - blood
Predictive Value of Tests
Prognosis
Receptors, Urokinase Plasminogen Activator - blood
Risk Assessment
Time Factors
title Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A50%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Circulating%20biomarkers%20for%20long-term%20cardiovascular%20risk%20stratification%20in%20apparently%20healthy%20individuals%20from%20the%20MONICA%2010%20cohort&rft.jtitle=European%20journal%20of%20preventive%20cardiology&rft.au=Frary,%20Charles%20Edward&rft.date=2020-04&rft.volume=27&rft.issue=6&rft.spage=570&rft.epage=578&rft.pages=570-578&rft.issn=2047-4873&rft.eissn=2047-4881&rft_id=info:doi/10.1177/2047487319885457&rft_dat=%3Cproquest_cross%3E2314248168%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2314248168&rft_id=info:pmid/31718257&rft_sage_id=10.1177_2047487319885457&rfr_iscdi=true